$AVAH

J.H. Whitney Equity Partners VII, LLC sold $36.5M of AVAH (indirect holdings)

J.H. Whitney Equity Partners VII, LLC sold 5,842,240 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $6.24 ($36.46M total) on 2026-06-03.

Original reporting
SEC EDGAR · J.H. Whitney Equity Partners VII, LLC
Published Jun 5, 2026, 3:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 3:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVAH
Bearish
medium confidence
Mentioned
$AVAH
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVAHBearishMed
01

Why it matters

The disclosure confirms a sizable open-market sale by a 10% owner at a specific price, which can affect short-term sentiment and perceived ownership conviction.

02

Market read

Material for AVAH as a major-owner trim at $6.24/share, filed June 5, with potential near-term sentiment impact.

03

What to watch

No 10b5-1 plan is cited, but the filing doesn’t disclose intent; traders should compare with prior Form 4 patterns and total remaining ownership to gauge signaling strength.

Relevance 7/10Novelty 7/10Timing: Filed June 5; sale executed June 3 (watch for follow-through in next sessions).

Background

This is an SEC Form 4 insider transaction disclosure for Aveanna Healthcare Holdings, Inc. (AVAH).

Company-level read

Ticker impact

$AVAHBearishMedium confidence
Context

J.H. Whitney Equity Partners VII, a 10% owner of Aveanna Healthcare, sold 5,842,240 shares in an open-market transaction on June 3.

Expected impact

Slight-to-moderate negative bias for AVAH around the filing/next sessions; magnitude likely limited without additional company-specific news.

Evidence & confidence

The filing provides a concrete sale size and price ($6.24) but no stated reason, and it explicitly notes no pre-arranged 10b5-1 plan.

Market effects

Limited sector read-through; this is company-specific ownership trimming rather than a sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

A large sale by a major owner can be routine liquidity management and may not reflect deteriorating fundamentals, especially if diversification is the driver.

Key entities

  • Aveanna Healthcare Holdings, Inc.

    Subject of the Form 4 insider transaction; 10%-owner sold shares on June 3.

  • J.H. Whitney Equity Partners VII, LLC

    Reporter of the open-market sale of AVAH shares.

Related articles

$AVAHMed

Bain, KKR, KV Asia shortlisted for Malaysia’s Avisena Healthcare stake sale as valuation hits US$368 million: sources

Bain Capital, KKR and KV Asia have been shortlisted to buy a 20–25% minority stake in Malaysia’s Avisena Healthcare, valuing the company at about RM1.5 billion (US$368m), according to two sources. Binding bids are due by end-July. The stake is estimated at RM300–400m. KKR and Bain declined comment; Avisena and KV Asia did not respond.